| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | 394 | 41 |
| Effect of exchange rate changes on cash | 9 | 7 |
| Net increase (decrease) in cash and cash equivalents | 2,789 | 626 |
| Cash and cash equivalents at beginning of period | 16,209 | - |
| Cash and cash equivalents at end of period | 18,998 | - |
LISATA THERAPEUTICS, INC. (LSTA)
LISATA THERAPEUTICS, INC. (LSTA)